Neuropathologist John Trojanowski Dies at 75

His work was pivotal to understanding the mechanisms of neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s.

Written byLisa Winter
| 2 min read
Bespectacled man wearing black shirt with arms folded looks at camera in front of lab cabinet
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Famed neuropathologist John Trojanowski, whose work uncovered the mechanisms of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, died in Philadelphia on February 8. Trojanowski was on life support after a fall left him paralyzed and complications set in. He was 75.

Trojanowski was born in Bridgeport, Connecticut, in 1946, but he didn’t stay there long. The New York Times reports that his father was in the military, and the family of nine would relocate every few years across the United States and in Germany. This nomadic way of life continued after Trojanowski’s birth and, after attending a few different schools, he graduated with a BA in German Studies from King’s College in Wilkes-Barre, Pennsylvania, in 1970. He then completed an MD/PhD program at Tufts University in 1976.

After graduation, he did an internship at Harvard University that taught him about neuropathology. During this time, he met a postdoc named ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies